ovarian cancer

Showing 51 - 75 of 1,589

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ovarian Cancer, Chemotherapeutic Toxicity Trial in Evanston (Fasting Mimicking Diet (Xentigen by L'Nutra), Carboplatin,

Not yet recruiting
  • Ovarian Cancer
  • Chemotherapeutic Toxicity
  • Fasting Mimicking Diet (Xentigen by L'Nutra)
  • +3 more
  • Evanston, Illinois
    NorthShore University HealthSystem
Jun 25, 2023

es in OVArian Cancer HRD+ Status in Russian Federation

Recruiting
  • Ovarian Cancer
    • Arkhangelsk, Russian Federation
    • +18 more
    Jun 26, 2023

    Immunotherapy-related CRP Kinetics in Metastatic Gynecological

    Recruiting
    • Gynecological Malignancies
    • +4 more
      • Tuebingen, Germany
        Department of Women's Health
      Jun 13, 2023

      Cervical Cancer, Endometrial Cancer, Ovarian Cancer Trial in Seoul (Patient registry)

      Recruiting
      • Cervical Cancer
      • +4 more
      • Patient registry
      • Seoul, Korea, Republic of
        Department of Obstetrics and Gynecology, University of Ulsan Col
      Jun 12, 2023

      Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

      Enrolling by invitation
      • Breast Cancer
      • +7 more
      • Dnipro, Ukraine
      • +1 more
      Jun 17, 2023

      Breast Cancer, Ovarian Cancer, Liposarcoma Trial (PF-07224826, Fulvestrant)

      Not yet recruiting
      • Breast Cancer
      • +5 more
      • (no location specified)
      Jun 7, 2023

      Ovarian Cancer Trial (68Ga-FAPi-46)

      Not yet recruiting
      • Ovarian Cancer
      • (no location specified)
      Jun 12, 2023

      Advanced Cancer, Advanced Malignancies, Bladder Cancer Trial (AB598, Zimberelimab, Carboplatin)

      Not yet recruiting
      • Advanced Cancer
      • +11 more
      • (no location specified)
      May 26, 2023

      Lung Cancer, Bronchial Cancer, Non Small Cell Lung Cancer Trial in Anqing (Recombinant oncolytic herpes simplex virus type 1

      Recruiting
      • Lung Cancer
      • +11 more
      • Recombinant oncolytic herpes simplex virus type 1 (R130)
      • Anqing, Anhui, China
        The PLA Navy Anqing Hospital
      May 23, 2023

      Solid Tumor, Adult, Advanced Solid Tumor, Head Neck Cancer Trial in Irving, San Antonio, West Valley City (SNS-101 (anti-VISTA),

      Recruiting
      • Solid Tumor, Adult
      • +19 more
      • Irving, Texas
      • +2 more
      May 24, 2023

      Elderly Ovarian Cancer Treated With Trabectedin and PLD

      Completed
      • Ovarian Cancer
      • Trabectedin and PLD
      • Córdoba, Spain
        Hospital Universitario Reina Sofía
      May 22, 2023

      Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial (Luveltamab tazevibulin, Pegfilgrastim)

      Not yet recruiting
      • Ovarian Cancer
      • +4 more
      • (no location specified)
      May 12, 2023

      Ovarian Cancer Trial in Houston (Hyperpolarized 13-C-pyruvate)

      Not yet recruiting
      • Ovarian Cancer
      • Hyperpolarized 13-C-pyruvate
      • Houston, Texas
        M D Anderson Cancer Center
      May 10, 2023

      Ovarian Cancer Trial in Padova (Laparoscopic Debulking Surgery in advanced ovarian cancer, Standard laparotomic Debulking

      Recruiting
      • Ovarian Cancer
      • Laparoscopic Debulking Surgery in advanced ovarian cancer
      • Standard laparotomic Debulking Surgery in advanced ovarian cancer
      • Padova, Padova, Veneto, Italy
        Azienda Ospedaliera Universitaria di Padova,
      May 8, 2023

      Ovarian Cancer in Expanded Access Program in Latin America

      Not yet recruiting
      • Ovarian Cancer
      • Observational study
      • (no location specified)
      May 4, 2023

      68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence

      Not yet recruiting
      • 68Ga-FAPI
      • +3 more
      • 68Ga-FAPI
      • Shanghai, Shanghai, China
        Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
      May 3, 2023

      Based on Quantitative Pharmacology in Patients With Pamipril

      Not yet recruiting
      • Ovarian Cancer
        • (no location specified)
        Apr 28, 2023

        Improved Diagnosis of Ovarian Cancer

        Recruiting
        • Ovarian Neoplasms
        • +6 more
          • Aarhus, Denmark
            Department of Gynaecology and Obstetrics, Aarhus University Hosp
          May 1, 2023

          VATS IN PATIENTS WITH ADVANCED OVARIAN MALIGNANCIES

          Active, not recruiting
          • Ovarian Cancer
          • VIDEO-ASSISTED THORACOSCOPIC SURGERY
          • Alexandria, Egypt
            Alexandria University
          Apr 21, 2023

          oncRNA Stratification of Cancer by Size and Stage

          Not yet recruiting
          • Kidney Cancer
          • +32 more
          • Exai oncRNA blood test
          • (no location specified)
          Apr 27, 2023

          Ovarian Cancer Trial in Goyang (Cisplatin)

          Not yet recruiting
          • Ovarian Cancer
          • Goyang, Gyeonggi, Korea, Republic of
            National Cancer Center
          Apr 24, 2023

          NSCLC, Non-Small Cell Lung Adenocarcinoma, Non-Small Cell Squamous Lung Cancer Trial in Grand Rapids, San Antonio, Fairfax

          Recruiting
          • Non-small Cell Lung Cancer
          • +10 more
          • Grand Rapids, Michigan
          • +2 more
          Apr 25, 2023

          Esophagus Cancer, Bladder Cancer, Liver Cancer Trial (Intravenous injection of P-IL-2, P-IL-2 plus Anti-PD-1 Monoclonal

          Not yet recruiting
          • Esophagus Cancer
          • +4 more
          • Intravenous injection of P-IL-2
          • P-IL-2 plus Anti-PD-1 Monoclonal Antibody
          • (no location specified)
          Apr 24, 2023

          68ga-FAPI-pet-ct Versus FDG-pet-ct for Ovarian Cancer

          Recruiting
          • Ovarian Cancer
          • 68Ga-FAPI-PET-CT
          • Xiamen, Fujian, China
            First Affiliated Hospital of Xiamen University
          Apr 19, 2023

          Advanced Lung Cancer, Ovarian Cancer Trial in Changsha, Yangzhou, Shanghai (AL2846 capsule)

          Recruiting
          • Advanced Lung Cancer
          • Ovarian Cancer
          • AL2846 capsule
          • Changsha, Hunan, China
          • +3 more
          Apr 4, 2023